EVADER Immune Suppressive AAV Based Gene Therapy for Repeat Dosing

Time: 12:00 pm
day: Track A - Day 2 AM

Details:

  • Clinical challenges addressed by EVADERTM technology
  • Scalable production of EVADERTM vectors
  • Anti-Capsid Immune Reduction by EVADERTM vectors

Speakers: